-
Congenital Muscular Dystrophy
A group of diseases causing muscle weakness at birth. Several defined genetic mutations cause muscles to break down faster than they can repair or grow. A child with CMD may have various neurological or physical impairments. Some children never gain the ability to walk, while others lose the ability as they grow older. Learn more...-
Events
- Kendal's Bash and CMD Splash!
- 7 August 2010
- Logan, IA
- CMD Family Conference 2010
- 14 August 2010
- Philadelphia, Pennsylvania
- Tullys Run for Owen
- 21 August 2010
- Madison, Wisconsin
- Fight for a Cure
- 21 August 2010
- Stratford, CT 06614
- CMD Scientific and Medical Advisory Board Meeting
- 13 September 2010
- Kendal's Bash and CMD Splash!
-
Navigation
Show Sub-Pages | Hide Sub-Pages
Category Archives: Research News
Richard Cloud Accepts Position as CEO of Prothelia
To all those that have supported Cure CMD and our efforts to find a treatment and cure Congenital Muscular Dystrophy I am very thankful. To further my involvement with finding a treatment or cure for Muscular Dystrophy, I have been offered and have accepted the position of CEO, Prothelia, Inc. I am and will continue [...]
Posted in Research News Comments closed
Santhera Receives Grant from Association Française contre les Myopathies for its Omigapil Program in Congenital Muscular Dystrophy
Liestal, Switzerland, November 3, 2009 – Santhera Pharmaceuticals (SIX: SANN), a Swiss specialty pharmaceutical company focused on orphan neuromuscular diseases, announced today that the French patient advocacy organization Association Française contre les Myopathies (AFM) awarded a grant of CHF 1 million for the development of Santhera’s SNT-317 (INN: omigapil) in Congenital Muscular Dystrophy (CMD).
Posted in Research News Comments closed
Ku70 improves MDC1A pathology
Ku70 which regulates Bax ( a regulator of cell apoptosis) helps improve MDC1A muscle cells and mouse
Posted in Research News Comments closed
Omigapil in MDC1A
Omigapil ameliorates the pathology in MDC1A
Posted in Research News Comments closed
Prevalence of Neuromuscular Disease, including CMD in Northern England
Prevalence of Neuromuscular disease, including CMD in Northern England. Estimates given for UCMD and Bethlem myopathy.
Posted in Research News Comments closed
Merosin Deficient CMD in Korea
CMD population in Korea surveyed for incidence of MDC1A
Posted in Research News Comments closed
Constipation Study in Dystrophic (mdx) Mice
This study examined whether mdx mice (mouse model for Duchenne muscular dystrophy) have intestinal changes that could help account for “constipation” symptoms in people with muscular dystrophy. The study looked for changes in the amount of time it takes the mouse stomach to empty a meal, the amount of time it takes food to get [...]
Posted in Research News Comments closed
Laminin
Current research suggest laminin, a protein that helps cells stick together may lead to enhanced muscle repair in muscular dystrophy.
Posted in Research News Comments closed
2 million dollar NIH award for CMD research
Dr. Kevin Campbell at the University of Iowa together with the Schultz laboratory at Scripps Research Institute secured a 2 million dollar two year NIH grant with the following 3 aims:
1. develop animal models for the dystroglycanopathy form of CMD as a resource for the scientific community
2. identify new genes that lead to dystroglycanopathy. Currently, only a [...]
Posted in Research News Comments closed